Clinical Trials

Lymphoma

Advanced or Recurrent

GOC LY-010:  A Phase III study of Cytoxan + Doxil +Vincristine + Prednisone (CDOP) and Rituxan  for elderly patients 70 years or older  with Non-Hodgkins Lymphoma who have not been treated previously with chemotherapy. [VCHOS]

LYMPHOCARE: Observational study on patients diagnosed  with Follicular B-cell Non-Hodgkins Lymphoma within the last 6 months. [VCHOS]

POI-02817:  A Phase III study of Nipent combined Cytoxan and Rituxan  for previously treated or untreated stage III or IV Low Grade B-cell Lymphoma. [VCHOS]

POI-0218:  A Phase III study of Nipent + Cytoxan + Rituxan for untreated or previously treated  Stage II Bulky Lymphoma.  [VCHOS]

For more information on VCHOS trials, please call Dianna Clark, RN, OCN at (805) 485-8709 ext 136 or email at dclark@venturaoncology.com.   

For more information on  UCLA network trials, please call  Pamela Riach, RN at (805) 485-8709 ext 129 or email at priach@mednet.ucla.edu.